We next tested if CTGF and CYR61 are the key YAP/TAZ targets modulating breast cancer cell motility as the expression of CTGF and CYR61 faithfully correlated with YAP/TAZ function compared to the other targets. This evidence concerns the gene CCN2 and breast carcinoma.